XML 15 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Operating Activities:    
Net income/(loss) $ (17,069,896) $ (19,754,705)
Adjustments to reconcile net loss to cash used in operating activities:    
Depreciation and amortization 95,238 75,645
Share-based compensation 2,243,445 5,478,734
Services paid in common stock 92,750  
Gain on lease modification (84,678)  
Loss on disposal of assets 77,210  
Operating lease asset amortization 667,526 694,229
Loss on equity method investment 232 27,361
Patent write off 26,419  
Impairment loss 3,283,715 0
Amortization of debt discount 1,809,566 2,609,389
Inventory write off and reserve expense 114,301  
Other   4,497
Changes in operating assets and liabilities:    
Accounts receivable 1,769 47,481
Inventories (124,760) (23,111)
Prepaid expenses and other current assets 192,273 (686,359)
Accounts payable (15,920) (47,008)
Related party payable (62,933) 22,164
Operating lease liabilities (649,991) (656,334)
Accrued interest 69,085 83,389
Accrued expenses (202,230) 1,618,053
Net cash (used in) operating activities (9,536,879) (10,506,575)
Investing Activities:    
Purchase of property, plant and equipment (3,857,783) (169,357)
Contributions to equity method investment   (83,559)
Patent activity costs (19,583) (12,556)
Net cash provided by (used in) investing activities (3,877,366) (265,472)
Financing Activities:    
Proceeds from issuance of convertible debt and warrants   13,500,000
Proceeds from issuance of stock and warrants 10,289,228 5,000,000
Proceeds from issuance of Series 1B Preferred Stock 900,000  
Payment of convertible debt and conversions payable (6,237,712)  
Payment of Series 1B Preferred Stock (900,000)  
Financing issuance cost (1,088,796) (2,206,695)
Net cash provided by (used in) financing activities 2,962,720 16,293,305
Effect of foreign exchange rate on cash 17,240  
Net change in cash and cash equivalents (10,434,285) 5,521,258
Cash and cash equivalents at beginning of period 11,483,018 5,961,760
Cash and cash equivalents at end of period 1,048,733 11,483,018
Supplemental Cash Flow Information:    
Cash paid for interest 293,842  
Non-Cash Transactions:    
Conversions of preferred stock, convertible notes, and conversions payable to equity 3,082,400 10,507,101
Series 1A preferred stock conversion   740
Operating lease assets obtained in exchange for operating lease liabilities   53,193
Purchase and return of equipment purchased on credit (202,558) 159,119
Conversion of bridge loan into common stock and warrants   $ 1,000,000
Conversion of prefunded warrants 247  
Down round deemed dividend $ 17,980,678